Date:2/27/2012

,219)(5,007)(4,667)Share-based compensation(74)(189)(320)(762)GAAP gross profit115,301143,095400,975486,441GAAP gross margin54.7%54.2%56.9%55.2%Non-GAAP selling expenses(40,565)(50,249)(117,911)(160,032)Non-GAAP as % of total revenues19.2%19.0%16.7%18.2%Amortization of acquired intangible assets (620)(712)(2,480)(2,588)Share-based compensation(709)(956)(2,569)(4,429)GAAP selling expenses(41,894)(51,917)(122,960)(167,049)GAAP as % of total revenues19.9%19.7%17.5%19.0%Non-GAAP general and administrative expenses(17,994)(16,734)(59,602)(66,950)Non-GAAP as % of total revenues8.5%6.3%8.5%7.6%Realignment costs - post acquisition(919)-(919)-Legal fees---(262)Share-based compensation(335)(955)(1,591)(3,118)GAAP general and administrative expenses(19,248)(17,689)(62,112)(70,330)GAAP as % of total revenues9.1%6.7%8.8%8.0%Non-GAAP research and development expenses(16,183)(24,531)(57,516)(77,965)Non-GAAP as % of total revenues7.7%9.3%8.2%8.9%Share-based compensation(580)(1,058)(2,800)(4,059)GAAP research and development expenses(16,763)(25,589)(60,316)(82,024)GAAP as % of total revenues7.9%9.7%8.6%9.3%Exhibit 5 MINDRAY MEDICAL INTERNATIONAL LIMITEDRECONCILIATION OF GAAP NET INCOME TO EARNINGS BEFORE INTEREST, TAXES,
DEPRECIATION AND AMORTIZATION(Dollars in thousands)Three months ended December 31,Year ended December 31, 2010 2011 2010 2011 US$US$US$US$(unaudited)(unaudited)(unaudited)(unaudited)GAAP net income41,04946,795155,466166,629Interest income(2,905)(7,258)(11,575)(20,816)Interest expense4374702,9001,390Provision for income taxes7,5138,22017,63122,647Earnings before interest and taxes ("EBIT")46,09448,227164,422169,850Depreciation4,6366,36718,77523,216Amortization2,5843,0198,88610,661Earnings befor
'/>"/>

SOURCE Mindray Medical International Limited Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26
2. Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline
3. Mindray Signs Agreement With Novation
4. Mindray Medical to Acquire a Controlling Stake in Hunan Changsha TDR Biotech
5. Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology
6. Mindray to Launch New DC-T6 Ultrasound System at RSNA
7. Mindray Announces Partnership with Epiphany Cardiography Products, LLC
8. Mindray to Hold Annual General Meeting in Hong Kong on December 19, 2011
9. Mindray Announces Up to $100 Million Share Repurchase Program
10. Mindray Announces Third Quarter 2011 Financial Results
11. Mindray Medical to Exhibit at MEDICA 2011 in Dusseldorf, Germany from November 16-19, 2011